1[1]Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clic Proc, 1984,59: 17-20
2[2]Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med, 1988,318: 1148-1152
3[3]Comess KA, DeRook FA, Beach KW, et al. Transeophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol, 1994, 23:1598-1603
4[4]Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patient less than 55 years of age. Stroke 1993, 24:1865-1872
5[5]Zerio C, Antonini-Canterin F, Pavan D, et al. Spontaneous closure of a patent foramen ovale and disappearance of impending paradoxical embolism after fibrinolytic therapy in the closure of massive pulmonary embolism. Am J cardiol, 1995, 76:422-424
6[6]Bridge ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Cirulation, 1992, 86:1902-1908
7[7]Butera G, Bini MR, Chessa M, et al. Transcatheter closure of patent foramen ovale in patient with cryptogenic stroke. Ital Heart J, 2001, 2:115-118
8[8]Sievert H, Babic UU, Haysdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol, 1998, 82:1405-1413
9[9]Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism.Long-term risk of recurrent thromboembilic events. Circulation,2000, 101:893-898
10[10]Hung J, Landzberg M, Jenkins K, et al. Closure of patent foramen ovale for paradoxical embolism:intermediate term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol, 2000, 35:1311-1316
